| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |